MX2007003426A - Formas cristalinas de un inhibidor del factor xa, pirazolo-[3, 4-c]-piridina. - Google Patents

Formas cristalinas de un inhibidor del factor xa, pirazolo-[3, 4-c]-piridina.

Info

Publication number
MX2007003426A
MX2007003426A MX2007003426A MX2007003426A MX2007003426A MX 2007003426 A MX2007003426 A MX 2007003426A MX 2007003426 A MX2007003426 A MX 2007003426A MX 2007003426 A MX2007003426 A MX 2007003426A MX 2007003426 A MX2007003426 A MX 2007003426A
Authority
MX
Mexico
Prior art keywords
pyrazolo
pyridine
inhibitor
factor
crystalline forms
Prior art date
Application number
MX2007003426A
Other languages
English (en)
Inventor
John D Dimarco
Margaret M Gleeson
Bang-Chi Chen
Mary F Malley
Gary Mcgeorge
Huiping Zhang
Denette K Murphy
Xiaotian S Yin
Steven R Fabian
Jasmine M Gupta
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36100111&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007003426(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MX2007003426A publication Critical patent/MX2007003426A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invencion proporciona las formas critalinas de la 1-(3-clorofenil)-7oxo-6-[4-(2-oxo-1(2H)piridinil)fenil]-4, 5, 6, 7-tetrahidro-1H-pirazolo[3, 4-c]piridin-3-carboxamida y los solvatos de la misma, y los procesos para la produccion de tales formas cristalinas, las composiciones farmaceuticas que comprenden tales formas cristalinas y los metodos de tratamiento de los trastornos tromboembolicos con tales formas cristalinas o las composiciones farmaceuticas.
MX2007003426A 2004-09-28 2005-09-27 Formas cristalinas de un inhibidor del factor xa, pirazolo-[3, 4-c]-piridina. MX2007003426A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61365604P 2004-09-28 2004-09-28
US11/235,519 US7388096B2 (en) 2004-09-28 2005-09-26 Crystalline forms of a factor Xa inhibitor
PCT/US2005/034512 WO2006036927A1 (en) 2004-09-28 2005-09-27 Crytalline forms of a pyrazolo `3, 4-c ! pyridine factor xa inhibitor

Publications (1)

Publication Number Publication Date
MX2007003426A true MX2007003426A (es) 2007-05-10

Family

ID=36100111

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007003426A MX2007003426A (es) 2004-09-28 2005-09-27 Formas cristalinas de un inhibidor del factor xa, pirazolo-[3, 4-c]-piridina.

Country Status (12)

Country Link
US (1) US7388096B2 (es)
EP (1) EP1819703A1 (es)
JP (1) JP2008514711A (es)
KR (1) KR20070067108A (es)
AU (1) AU2005289599A1 (es)
BR (1) BRPI0516171A (es)
CA (1) CA2582223A1 (es)
IL (1) IL182148A0 (es)
MX (1) MX2007003426A (es)
NO (1) NO20071653L (es)
RU (1) RU2007115859A (es)
WO (1) WO2006036927A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7304157B2 (en) 2004-09-28 2007-12-04 Bristol-Myers Squibb Company Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
AR053990A1 (es) 2004-12-15 2007-05-30 Bristol Myers Squibb Co Formas cristalinas de un compuesto de pirazolpiridina inhibidor de factor xa. composiciones farmaceuticas y procesos de obtencion.
DE102008037025C5 (de) * 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
CN105384739B (zh) * 2014-09-02 2020-03-20 石药集团中奇制药技术（石家庄）有限公司 吡唑并[3,4-c]吡啶类衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI320039B (en) * 2001-09-21 2010-02-01 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
ATE439360T1 (de) 2001-09-21 2009-08-15 Bristol Myers Squibb Co Lactamhaltige verbindungen und ihre derivate als faktor-xa-hemmer
US7304157B2 (en) * 2004-09-28 2007-12-04 Bristol-Myers Squibb Company Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Also Published As

Publication number Publication date
JP2008514711A (ja) 2008-05-08
US20060069118A1 (en) 2006-03-30
AU2005289599A1 (en) 2006-04-06
KR20070067108A (ko) 2007-06-27
NO20071653L (no) 2007-03-30
CA2582223A1 (en) 2006-04-06
IL182148A0 (en) 2007-07-24
EP1819703A1 (en) 2007-08-22
BRPI0516171A (pt) 2008-08-26
US7388096B2 (en) 2008-06-17
WO2006036927A1 (en) 2006-04-06
RU2007115859A (ru) 2008-11-10

Similar Documents

Publication Publication Date Title
CL2008002717A1 (es) 3-(1-clorofenil)-7-oxo-6-[4-(2-oxo-1(2h)piridinil)fenil]-4,5,6,7-tetrahidro-1h-pirazolo[3,4-c]piridin-3-carboxamida y 3-(1-hidroxi-1-metil-etil)-1-(a-metoxi-fenil)-6-[4-(2-oxo-2h-piridin-1-il)-fenil]-1,4,5,6-tetrahidro-pirazolo[3,4-c]piridin-7-ona; composicion farmaceutica; combinacion farmaceutica y uso en el tratamiento de un desorden tromboembolico
HK1065033A1 (en) Thiazole compounds useful as inhibitors or proteinkinases
ZA200306419B (en) Phenyl derivatives.
WO2002000651A3 (en) Factor xa inhibitors
WO2005034866A3 (en) Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors
CA2603830A1 (en) PYRIDINE [2,3-B] PYRAZINONES
WO2005046603A3 (en) Pyridine compounds
AU2003297160A1 (en) Benzisoxazole derivatives useful as inhibitors of protein kinases
WO2005037198A3 (en) Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
WO2005028443A3 (en) Protein tyrosine kinase enzyme inhibitors
NO20062256L (no) Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner
WO2006061417A3 (en) Macrocyclic quinazole derivatives and their use as mtki
WO2005037197A3 (en) Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
WO2003029200A3 (en) Compounds useful as reversible inhibitors of cysteine proteases
AU2002358390A1 (en) Novel compounds
WO2004099197A3 (de) Substituierte oxyarene und deren verwendung zur bekämpfung von schädlingen
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
NO20042861L (no) N-(3-butyn-1-yl)-N-hydroksyurea
WO2002080853A3 (en) Fused heterocyclic inhibitors of factor xa
WO2004043379A3 (en) Chemical compounds
WO2004032908A3 (en) Method of inhibiting angiogenesis
MX2007003426A (es) Formas cristalinas de un inhibidor del factor xa, pirazolo-[3, 4-c]-piridina.
WO2002014313A3 (de) Neue beta-amyloid inhibitoren, verfahren zu deren herstellung und deren verwendung als arzneimittel
WO2004072029A3 (en) Pyrazolopyridazines useful as inhibitors of protein kinases
TW200634011A (en) Crystalline forms of a factor xa inhibitor

Legal Events

Date Code Title Description
FA Abandonment or withdrawal